血小板计数短期动态变化对ICU脓毒症患者预后的临床预测价值:成人回顾性队列研究
该回顾性队列研究纳入2015年11月至2018年10月上海交通大学附属第一人民医院南院ICU收治的220例Sepsis-3诊断的成人脓毒症患者,按28天内是否死亡分为死亡组(61例)和存活组(159例),28天死亡率为27.7%。死亡组年龄更大、慢性心血管/慢性肾脏/免疫系统疾病更多、APACHE II评分、SOFA评分、DIC评分更高、第1天和第7天PLT更低、持续性或获得性血小板减少发生率更高、PCT和IL-6更高、器官功能(心脏、肾脏、凝血)更差。ROC曲线显示SOFA评分预测28天预后的AUC最高(0.878),第7天PLT的AUC高于第1天(0.862 vs. 0.674)。多因素Logistic回归显示SOFA评分(OR=1.423)、肌钙蛋白I(OR=2.056)和持续性或获得性血小板减少(OR=13.028)是28天死亡的独立危险因素;基于三者构建的多参数模型AUC为0.926,最佳截断值0.398时敏感度76.8%、特异度92.8%。作者认为住院第一周内持续性或获得性血小板减少对ICU脓毒症患者预后有较重要的临床预测价值,针对血小板减少的临床干预可能成为这类脓毒症患者新的潜在治疗方法。
要点
- ICU脓毒症患者入ICU第一周内持续性血小板减少(第一周PLT均<100×10^9/L)或获得性血小板减少(入ICU当天PLT≥100×10^9/L但第一周下降超过50%)是28天死亡的独立危险因素(OR=13.028,95%CI 4.033-42.090,P<0.001)。
- SOFA评分(OR=1.423,95%CI 1.089-1.859,P=0.010)和肌钙蛋白I(OR=2.056,95%CI 1.057-3.999,P=0.034)也是ICU脓毒症患者28天死亡的独立危险因素。
- 基于SOFA评分、肌钙蛋白I和持续性或获得性血小板减少构建的多参数模型预测28天死亡的AUC为0.926,最佳截断值0.398时敏感度76.8%、特异度92.8%。
- 第7天PLT预测28天预后的AUC为0.862,高于第1天PLT的AUC 0.674;SOFA评分AUC为0.878,其他临床指标AUC均<0.8。
- 该研究为单中心回顾性队列,纳入220例成人脓毒症患者,28天死亡率为27.7%(61/220)。
适用人群与场景
- 纳入标准:年龄18至80岁、符合Sepsis-3诊断、2015年11月至2018年10月入住上海交通大学附属第一人民医院南院ICU的脓毒症患者。
- 研究场景:ICU收治的成人脓毒症患者,病情阶段为入ICU后第一周。
诊断标准与关键阈值
- 脓毒症诊断标准:Sepsis-3。
- 持续性血小板减少:入ICU后第一周内PLT均<100×10^9/L。
- 获得性血小板减少:入ICU当天PLT≥100×10^9/L,但入ICU后第一周内下降超过50%。
- 多参数模型预测28天死亡的最佳截断值为0.398,该截断值下敏感度76.8%、特异度92.8%。
红旗征与不能漏的情况
- 入ICU第一周内出现持续性血小板减少(PLT均<100×10^9/L)或获得性血小板减少(入ICU当天PLT≥100×10^9/L但第一周下降超过50%),提示28天死亡风险显著升高(OR=13.028,95%CI 4.033-42.090,P<0.001)。
- SOFA评分升高(OR=1.423,95%CI 1.089-1.859,P=0.010)和肌钙蛋白I升高(OR=2.056,95%CI 1.057-3.999,P=0.034)提示28天死亡风险增加。
研究设计与关键结果
- 研究类型:回顾性队列研究;样本量220例成人脓毒症患者;28天内死亡61例、存活159例,28天死亡率27.7%。
- 与存活组相比,死亡组年龄更大、慢性心血管疾病/慢性肾脏疾病/免疫系统疾病更多、APACHE II评分、SOFA评分、DIC评分更高、第1天和第7天PLT更低、持续性或获得性血小板减少发生率更高、PCT和IL-6更高、器官功能(心脏、肾脏、凝血)更差,差异有统计学意义;性别、疾病类型、感染部位、病原体、肝功能差异无统计学意义。
- ROC曲线分析:三种疾病严重程度评分均可预测ICU脓毒症28天预后,SOFA评分AUC最高(0.878);第7天PLT的AUC高于第1天(0.862 vs. 0.674);其他临床指标AUC均<0.8。
- 多因素Logistic回归:SOFA评分(OR=1.423,95%CI 1.089-1.859,P=0.010)、肌钙蛋白I(OR=2.056,95%CI 1.057-3.999,P=0.034)、持续性或获得性血小板减少(OR=13.028,95%CI 4.033-42.090,P<0.001)为28天死亡的独立危险因素。
- 基于SOFA评分、肌钙蛋白I和持续性或获得性血小板减少构建的多参数模型预测28天死亡的AUC为0.926,最佳截断值0.398时敏感度76.8%、特异度92.8%。
证据类型、等级与局限
- 证据类型:回顾性队列研究(单中心)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,住院第一周内持续性或获得性血小板减少对ICU脓毒症患者预后有较重要的临床预测价值。
- 作者认为,针对血小板减少的临床干预可能成为这类脓毒症患者新的潜在治疗方法。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore clinical predictive value of short-term dynamic changes in platelet counts (PLT) for prognosis of sepsis patients in intensive care unit (ICU).
METHODS: A retrospective cohort study was conducted. The patients aging 18 to 80 years old who were diagnosed by Sepsis-3 admitted to ICU of South Branch of Shanghai General Hospital from November 2015 to October 2018 were enrolled. According to whether the patients died within 28 days, they were divided into death and survival groups. General information and clinical baseline data [including disease severity score, infection biomarkers, PLT and organ function parameters (cardiac, liver, kidney, coagulation) and inflammatory cytokines] between the two groups were compared. Based on clinical indicators which had statistically significance, receiver operating characteristic (ROC) curve was drawn to predict the prognosis of the patients within 28 days. Then, risk factors of 28-day mortality of sepsis patients in ICU were screened by univariate and multivariate Logistic regression analysis. On the basis of multivariate Logistic regression analysis results, a multiparameter model was built, and the ROC curve was drawn to predict its prognosis within 28 days.
RESULTS: A total of 220 sepsis patients were enrolled. Among them, 61 patients died and 159 patients survived within 28 days with a 28-day mortality of 27.7%. Compared with the survival group, the patients in the death group were senior in age, more likely to suffer from chronic cardiovascular, chronic kidney and immune system disease, had higher scores in acute physiologic and chronic health evaluation II (APACHE II) score, sequential organ failure assessment (SOFA) score, disseminated intravascular coagulation (DIC) score and less PLT on the 1st and 7th day, sustained a higher incidence of persistent thrombocytopenia (PLT were all < 100×109/L in the first week after ICU admission) or acquired thrombocytopenia (PLT ≥ 100×109/L on the day of ICU admission, but dropped over 50% during the first week after ICU admission), were subjected to higher procalcitonin (PCT) and interleukin-6 (IL-6) levels and endured worse organ function (cardiac, kidney, coagulation) with statistically significant differences. However, there was no significant difference in gender, disease type, infection sites, pathogens or liver function. The ROC curve analysis for the 28-day prognosis of sepsis illustrated that the three disease severity scores could predict the 28-day prognosis of sepsis in ICU, and the area under ROC curve (AUC) of SOFA score was the highest (AUC = 0.878). The AUC of PLT on the 7th day was higher than that on the 1st day (AUC: 0.862 vs. 0.674), and the AUC of other clinical indicators were all < 0.8. Univariate and multivariate Logistic regression analysis showed that SOFA score [odds ratio (OR) = 1.423, 95% confidence interval (95%CI) was 1.089-1.859, P = 0.010], troponin I (TnI; OR = 2.056, 95%CI was 1.057-3.999, P = 0.034), and persistent or acquired thrombocytopenia (OR = 13.028, 95%CI was 4.033-42.090, P < 0.001) were three independent risk factors for 28-day mortality of the sepsis patients in ICU. Based on the multivariate Logistic regression analysis results, a multiparameter model was built with SOFA score, TnI and persistent or acquired thrombocytopenia, which showed a AUC of 0.926 to predict the 28-day mortality of sepsis patients in ICU. When the optimum cut-off value was 0.398 in the model, the sensitivity was 76.8%, and the specificity was 92.8%.
CONCLUSIONS: Persistent or acquired thrombocytopenia within the first week of hospitalization proves to have a relatively momentous clinical predictive value for prognosis of sepsis patients in ICU. Clinical intervention focusing on thrombocytopenia may become a new potential therapy for these sepsis patients.
参考来源
- Zhou Z, Xie Y, Feng T, et al. [Clinical predictive value of short-term dynamic changes in platelet counts for prognosis of sepsis patients in intensive care unit: a retrospective cohort study in adults]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32385993. doi:10.3760/cma.j.cn121430-20190909-00069
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。